Turning Microbial Discovery Into Market Advantage

A multinational fertilizer production and distribution company sought to expand its biological portfolio with a nitrogen-fixing product that could complement synthetic fertilizer programs without sacrificing yield stability.

Using our advanced microbial gene-editing platform, BioConsortia optimized a high-performing microbial portfolio with consistent nitrogen contribution across diverse ag environments.

• Demonstrated yield stability under reduced nitrogen regimes
• Multi-location, multi-season validation across key row crop-growing regions
• Successful scale-up to commercial fermentation volumes Outcome The partner expanded the collaboration to include additional crop segments and geographies

A seed enhancement and forage company sought to expand its biological seed treatment portfolio with a wildtype nitrogen-fixing product that could improve grower profitability under mandated synthetic fertilizer reductions.

Using our AMS platform, BioConsortia identified and optimized a high-performing microbial strain with consistent nitrogen contribution.

• Demonstrated yield stability under reduced nitrogen regimes
• Multi-location validation across key corn, cereal and forage-growing regions
• Clear emergence, early vigor and crop quality advantages
• Strong early market adoption, driven by grower ease of use and consistent results

“AlwaysN® can help reduce the pinch coming out of winter and kickstart the growing season sooner"
- Cereals Grower, New Zealand

A global crop protection company aimed to diversify its fungicide portfolio with next-generation microbial fungicide solutions to meet evolving sustainability demands.

• Rapid identification of high-performing microbial fungicides, with unique spectrum of control
• Data-backed field validation across multiple crops and fully characterized mode of action not likely to exacerbate fungicide resistance
• Regulatory pathway support
• Manufacturing scale-up and supply

• Reduced internal R&D timelines
• Expanded the company’s understanding of integrated disease control approaches
• Strengthened sustainability positioning
• Expanded biological pipeline